Ultralife Corporation
US ˙ NasdaqGM ˙ US9038991025

Introduction

This page provides a comprehensive analysis of the known insider trading history of Philip A Fain. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Philip A Fain has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ULBI / Ultralife Corporation CFO and Treasurer 137,809
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Philip A Fain. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ULBI / Ultralife Corporation - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ULBI / Ultralife Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2022-12-07 ULBI FAIN PHILIP A 1,500 3.9900 1,500 3.9900 5,985 299 11.3700 11,070 184.96
2021-12-16 ULBI FAIN PHILIP A 300 5.4518 300 5.4518 1,636
2021-12-16 ULBI FAIN PHILIP A 634 5.4518 634 5.4518 3,456
2021-12-16 ULBI FAIN PHILIP A 906 5.4518 906 5.4518 4,939
2020-02-27 ULBI FAIN PHILIP A 591 7.2500 591 7.2500 4,285
2020-02-27 ULBI FAIN PHILIP A 2,080 7.3000 2,080 7.3000 15,184
2020-02-26 ULBI FAIN PHILIP A 100 7.2500 100 7.2500 725
2017-12-15 ULBI FAIN PHILIP A 3,552 6.2000 3,552 6.2000 22,022
2013-08-15 ULBI FAIN PHILIP A 10,000 3.7500 10,000 3.7500 37,500

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ULBI / Ultralife Corporation Insider Trades
Insider Sales ULBI / Ultralife Corporation - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ULBI / Ultralife Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ULBI / Ultralife Corporation Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Philip A Fain as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2024-04-19 2024-04-17 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
M - Exercise 7,179 137,809 5.50 5.71 40,974 786,545
2023-05-23 2023-05-19 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
M - Exercise 630 130,630 0.48 4.29 2,703 560,429
2022-12-08 2022-12-07 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 1,500 130,000 1.17 3.99 5,985 518,700
2022-03-04 2022-03-02 4 ULBI ULTRALIFE CORP
Stock Options
M - Exercise 30,000 0 -100.00
2022-03-04 2022-03-02 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
M - Exercise 8,500 128,500 7.08 3.71 31,538 476,774
2021-12-16 2021-12-16 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 906 120,000 0.76 5.45 4,939 654,216
2021-12-16 2021-12-16 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 634 119,094 0.54 5.45 3,456 649,277
2021-12-16 2021-12-16 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 300 118,460 0.25 5.45 1,636 645,820
2021-10-22 2021-10-20 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 20,000 20,000
2021-03-03 2021-03-01 4 ULBI ULTRALIFE CORP
Stock Options
M - Exercise 70,000 0 -100.00
2021-03-03 2021-03-01 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
M - Exercise 23,160 118,160 24.38 3.94 91,213 465,361
2020-04-23 2020-04-22 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 20,000 20,000
2020-02-28 2020-02-27 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 2,080 95,000 2.24 7.30 15,184 693,500
2020-02-28 2020-02-27 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 591 92,920 0.64 7.25 4,285 673,670
2020-02-28 2020-02-26 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 100 92,329 0.11 7.25 725 669,385
2019-07-25 2019-07-23 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 25,000 25,000
2019-01-02 2018-12-28 4 ULBI ULTRALIFE CORP
Stock Options
M - Exercise 20,000 0 -100.00
2019-01-02 2018-12-28 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
M - Exercise 6,823 92,229 7.99 3.98 27,153 367,044
2018-12-06 2018-12-03 4 ULBI ULTRALIFE CORP
Stock Options
M - Exercise -50,000 0 -100.00
2018-12-06 2018-12-03 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
M - Exercise 15,406 85,406 22.01 4.42 68,122 377,648
2018-04-19 2018-04-18 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 20,000 20,000
2017-12-15 2017-12-15 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
P - Purchase 3,552 70,000 5.35 6.20 22,022 434,000
2017-04-21 2017-04-19 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 20,000 20,000
2016-12-02 2016-11-30 4 ULBI ULTRALIFE CORP
Stock Options
M - Exercise -33,000 0 -100.00
2016-12-02 2016-11-30 4 ULBI ULTRALIFE CORP
Common Stock; $.10 par value
M - Exercise 5,162 66,448 8.42 3.91 20,176 259,712
2016-06-03 2016-06-01 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 20,000 20,000
2015-03-09 2015-03-03 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 30,000 30,000
2014-03-06 2014-03-04 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 70,000 70,000
2013-08-15 2013-08-15 4 ULBI ULTRALIFE CORP
Common Stock , $.10 par value
P - Purchase 10,000 61,286 19.50 3.75 37,500 229,822
2012-01-04 2012-01-03 4 ULBI ULTRALIFE CORP
Common Stock (Right to Buy)
A - Award 20,000 20,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)